Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer

PURPOSE: The recent publication of the ACOSOG Z1031 trial results demonstrated that Ki-67 proliferation marker-based neoadjuvant endocrine therapy response monitoring could be used for tailoring the use of adjuvant chemotherapy in ER+HER2-negative breast cancer patients. In this paper, we describe t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Autores principales: Goncalves, Rodrigo, DeSchryver, Katherine, Ma, Cynthia, Tao, Yu, Hoog, Jeremy, Cheang, Maggie, Crouch, Erika, Dahiya, Neha, Sanati, Souzan, Barnes, Michael, Sarian, Luis Otávio Zanatta, Olson, John, Allred, Donald Craig, Ellis, Matthew J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5543203/
https://ncbi.nlm.nih.gov/pubmed/28612227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4329-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares